Sapience Investments LLC Increases Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sapience Investments LLC lifted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 64.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 78,885 shares of the company's stock after buying an additional 31,056 shares during the quarter. Acadia Healthcare makes up about 1.8% of Sapience Investments LLC's investment portfolio, making the stock its 12th largest position. Sapience Investments LLC owned about 0.08% of Acadia Healthcare worth $3,128,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Wellington Management Group LLP boosted its stake in shares of Acadia Healthcare by 0.7% during the fourth quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock valued at $465,283,000 after purchasing an additional 76,490 shares during the period. FMR LLC boosted its position in Acadia Healthcare by 257.9% in the fourth quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after buying an additional 4,489,681 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Acadia Healthcare by 18.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock worth $126,189,000 after purchasing an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares during the period. Finally, Madison Avenue Partners LP purchased a new stake in Acadia Healthcare in the 4th quarter worth approximately $76,339,000.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. KeyCorp cut their price objective on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Wednesday, May 14th. Guggenheim initiated coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target for the company. Mizuho lowered their price target on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Royal Bank of Canada reduced their target price on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. Finally, Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday. Four research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $47.94.

Acadia Healthcare Trading Down 2.6%

ACHC traded down $0.61 during mid-day trading on Thursday, hitting $22.90. 522,858 shares of the stock were exchanged, compared to its average volume of 1,708,458. The firm's fifty day moving average is $25.96 and its two-hundred day moving average is $35.22. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41. The company has a market cap of $2.11 billion, a PE ratio of 7.51, a PEG ratio of 1.46 and a beta of 1.01. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. The firm had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's revenue for the quarter was up .3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.84 earnings per share. Equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.